BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17121805)

  • 1. E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein.
    Handa K; Yugawa T; Narisawa-Saito M; Ohno S; Fujita M; Kiyono T
    J Virol; 2007 Feb; 81(3):1379-89. PubMed ID: 17121805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase.
    Nakagawa S; Huibregtse JM
    Mol Cell Biol; 2000 Nov; 20(21):8244-53. PubMed ID: 11027293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein.
    Kiyono T; Hiraiwa A; Fujita M; Hayashi Y; Akiyama T; Ishibashi M
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11612-6. PubMed ID: 9326658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation.
    Jeong KW; Kim HZ; Kim S; Kim YS; Choe J
    Oncogene; 2007 Jan; 26(4):487-99. PubMed ID: 16878151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase.
    Pim D; Thomas M; Javier R; Gardiol D; Banks L
    Oncogene; 2000 Feb; 19(6):719-25. PubMed ID: 10698489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
    Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
    J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells.
    Talis AL; Huibregtse JM; Howley PM
    J Biol Chem; 1998 Mar; 273(11):6439-45. PubMed ID: 9497376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.
    Zhang Y; Dasgupta J; Ma RZ; Banks L; Thomas M; Chen XS
    J Virol; 2007 Apr; 81(7):3618-26. PubMed ID: 17267502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus.
    Karlsson OA; Ramirez J; Öberg D; Malmqvist T; Engström Å; Friberg M; Chi CN; Widersten M; Travé G; Nilsson MT; Jemth P
    Sci Rep; 2015 Mar; 5():9382. PubMed ID: 25797137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of the hDlg/SAP97 PDZ2 domain and its mechanism of interaction with HPV-18 papillomavirus E6 protein.
    Liu Y; Henry GD; Hegde RS; Baleja JD
    Biochemistry; 2007 Sep; 46(38):10864-74. PubMed ID: 17713926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent.
    Tomaić V; Pim D; Banks L
    Virology; 2009 Oct; 393(1):7-10. PubMed ID: 19700180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase.
    Kao WH; Beaudenon SL; Talis AL; Huibregtse JM; Howley PM
    J Virol; 2000 Jul; 74(14):6408-17. PubMed ID: 10864652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of the PDZ-binding motif of HPV 16 E6 protein in oncogenic transformation of human cervical keratinocytes.
    Yoshimatsu Y; Nakahara T; Tanaka K; Inagawa Y; Narisawa-Saito M; Yugawa T; Ohno SI; Fujita M; Nakagama H; Kiyono T
    Cancer Sci; 2017 Jul; 108(7):1303-1309. PubMed ID: 28440909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cottontail rabbit papillomavirus E6 oncoproteins with the hDlg/SAP97 tumor suppressor.
    Du M; Fan X; Hanada T; Gao H; Lutchman M; Brandsma JL; Chishti AH; Chen JJ
    J Cell Biochem; 2005 Apr; 94(5):1038-45. PubMed ID: 15669058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Drosophila Model of HPV E6-Induced Malignancy Reveals Essential Roles for Magi and the Insulin Receptor.
    Padash Barmchi M; Gilbert M; Thomas M; Banks L; Zhang B; Auld VJ
    PLoS Pathog; 2016 Aug; 12(8):e1005789. PubMed ID: 27537218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes.
    Watson RA; Thomas M; Banks L; Roberts S
    J Cell Sci; 2003 Dec; 116(Pt 24):4925-34. PubMed ID: 14625386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.
    Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of human papillomavirus E6 by protein kinase A: conditional degradation of human discs large protein by oncogenic E6.
    Kühne C; Gardiol D; Guarnaccia C; Amenitsch H; Banks L
    Oncogene; 2000 Nov; 19(51):5884-91. PubMed ID: 11127819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1.
    Drews CM; Case S; Vande Pol SB
    PLoS Pathog; 2019 Apr; 15(4):e1007575. PubMed ID: 31002735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.